HK1095536A1 - 1-(3-methyl-2,4-dimethoxyphenyl)-3-(2',4'-dihydroxyphenyl)-propane as a potent tyrosinase inhibitor - Google Patents
1-(3-methyl-2,4-dimethoxyphenyl)-3-(2',4'-dihydroxyphenyl)-propane as a potent tyrosinase inhibitorInfo
- Publication number
- HK1095536A1 HK1095536A1 HK07102730.4A HK07102730A HK1095536A1 HK 1095536 A1 HK1095536 A1 HK 1095536A1 HK 07102730 A HK07102730 A HK 07102730A HK 1095536 A1 HK1095536 A1 HK 1095536A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- binuclear
- present
- diarylalkanes
- diarylalkanols
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/74—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/367—Halogenated derivatives polycyclic non-condensed, containing only six-membered aromatic rings as cyclic parts, e.g. halogenated poly-hydroxyphenylalkanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/32—Preparation of ethers by isomerisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/12—Eight-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57559904P | 2004-05-28 | 2004-05-28 | |
PCT/US2005/018884 WO2005117849A1 (en) | 2004-05-28 | 2005-05-27 | Diarylalkanes as potent inhibitors of binuclear enzymes |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1095536A1 true HK1095536A1 (en) | 2007-06-29 |
Family
ID=35462712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07102730.4A HK1095536A1 (en) | 2004-05-28 | 2007-03-13 | 1-(3-methyl-2,4-dimethoxyphenyl)-3-(2',4'-dihydroxyphenyl)-propane as a potent tyrosinase inhibitor |
Country Status (15)
Country | Link |
---|---|
US (8) | US20050267047A1 (de) |
EP (1) | EP1748767B1 (de) |
JP (1) | JP5128277B2 (de) |
KR (2) | KR101236527B1 (de) |
CN (4) | CN103356514A (de) |
AT (1) | ATE538778T1 (de) |
AU (1) | AU2005249493B2 (de) |
CA (1) | CA2567801C (de) |
ES (1) | ES2384506T3 (de) |
HK (1) | HK1095536A1 (de) |
MX (1) | MXPA06013705A (de) |
PL (1) | PL1748767T3 (de) |
RU (2) | RU2466981C1 (de) |
WO (1) | WO2005117849A1 (de) |
ZA (1) | ZA200609927B (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023200786A1 (en) | 2022-04-12 | 2023-10-19 | Unigen, Inc. | Diarylalkane compounds and compositions for use with skin aging and methods of production thereof |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200609927B (en) | 2004-05-28 | 2008-07-30 | Unigen Pharmaceuticals Inc | Diarylalkanes as potent inhibitors of binuclear enzymes |
DE102005044156A1 (de) * | 2005-09-15 | 2007-03-29 | Riemser Arzneimittel Ag | Substituierte Acetophenonderivate |
FR2910808B1 (fr) * | 2006-12-29 | 2009-04-10 | Lvmh Rech | Utilisation en cosmetique de la l-2-thiohistidine ou d'un de ses derives comme agent depigmentant. |
KR100909768B1 (ko) * | 2007-10-31 | 2009-07-29 | 주식회사 코리아나화장품 | 감태나무 추출물을 유효성분으로 함유하는 피부노화 방지용화장료 조성물 |
KR102107460B1 (ko) * | 2008-07-21 | 2020-05-08 | 유니젠, 인크. | 일련의 피부-화이트닝(라이트닝) 화합물 |
US8846012B2 (en) * | 2008-12-22 | 2014-09-30 | Pola Chemical Industries Inc. | Melanin production inhibitor |
US20110038852A1 (en) * | 2009-06-10 | 2011-02-17 | 3-V Biosciences, Inc. | Antivirals that target transporters, carriers, and ion channels |
MX2012007256A (es) | 2009-12-22 | 2013-01-29 | Avon Prod Inc | Composicioes estimuladoras de paxilina y usos comesticos de las mismas. |
CN105362151A (zh) * | 2010-03-31 | 2016-03-02 | 株式会社爱茉莉太平洋 | 含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 |
KR101831366B1 (ko) * | 2010-06-18 | 2018-04-04 | (주)아모레퍼시픽 | 닥나무 추출물 제조 방법 |
KR101681683B1 (ko) * | 2010-07-02 | 2016-12-01 | (주)아모레퍼시픽 | 닥나무의 꽃과 열매 추출물을 함유하는 피부 미백용 피부 외용제 조성물 |
KR101830860B1 (ko) * | 2010-07-13 | 2018-02-21 | (주)아모레퍼시픽 | 닥나무 추출물을 함유하는 항노화용 화장료 조성물 |
JP5944896B2 (ja) * | 2010-07-02 | 2016-07-05 | 株式会社アモーレパシフィックAmorepacific Corporation | コウゾ抽出物を含有する組成物 |
KR101769935B1 (ko) * | 2010-07-14 | 2017-08-21 | (주)아모레퍼시픽 | 닥나무 추출물을 제조하는 방법, 그에 의해 제조된 닥나무 추출물 및 이를 포함하는 화장료 조성물 |
KR101761771B1 (ko) * | 2010-07-14 | 2017-07-26 | (주)아모레퍼시픽 | 닥나무 또는 그 추출물의 발효방법, 그 발효 추출물 및 이를 포함하는 화장료 조성물 |
CN103189046B (zh) | 2010-09-09 | 2016-09-07 | 玫琳凯有限公司 | 包含植物提取物的局部护肤制剂 |
EP2889384B1 (de) * | 2010-12-30 | 2016-09-28 | Avon Products, Inc. | Verfahren zur Erkennung von aktiven Stoffen zur Verbesserung des Erscheinungsbildes menschlicher Haut |
FR2970416B1 (fr) * | 2011-01-18 | 2013-02-22 | Fabre Pierre Dermo Cosmetique | Nouveaux derives monoterpeniques de chalcone ou dihydrochalcone et leur utilisation comme depigmentants |
AU2012231008B2 (en) | 2011-03-24 | 2017-05-11 | Unigen, Inc. | Compounds and methods for preparation of diarylpropanes |
DE102011114780A1 (de) * | 2011-10-01 | 2013-04-04 | Merck Patent Gmbh | Verwendung von Propanol- und Propenolderivaten als Antioxidantien |
FR2984730A1 (fr) | 2011-12-22 | 2013-06-28 | Diverchim | Nouvelles compositions cosmetiques anti-age et depigmentantes |
KR101424361B1 (ko) | 2012-07-03 | 2014-08-01 | 영남대학교 산학협력단 | 하이드록시 챨콘 화합물을 유효성분으로 함유하는 항염 조성물 |
JP6207336B2 (ja) * | 2012-11-12 | 2017-10-04 | 日本ポリプロ株式会社 | ジオール化合物及びオレフィン重合用触媒並びにオレフィン重合体の製造方法 |
MD4274C1 (ro) * | 2013-05-27 | 2014-09-30 | Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы | Azotat de trans-bis(dimetilglioximato)bis(nicotinamid)cobalt(III)dihidrat, ce manifestă proprietăţi antioxidante la plante |
WO2015122858A1 (en) | 2014-02-15 | 2015-08-20 | Erdal Can Alkoçlar | A composition containing synthetic components formed for suppressing ribonucleotide reductase |
FR3030510B1 (fr) * | 2014-12-22 | 2017-02-03 | Oreal | Composes 1-phenyl (3,4-disubstitues), 2-phenyl (3,4-disubstitues) ethane et leur utilisation |
US20160214918A1 (en) * | 2015-01-22 | 2016-07-28 | Kaohsiung Medical University | Composition for treating metabolic syndrome and a preparation method thereof |
BR112017022026B1 (pt) | 2015-04-15 | 2021-09-28 | Natura Cosméticos S.A. | Formulação cosmética de hidratação prolongada compreendendo manteiga de ucuuba, seus usos, produto e kit cosmético compreendendo a mesma |
CN105726410B (zh) * | 2016-03-29 | 2019-01-04 | 中国科学院成都生物研究所湖州生物资源利用与开发创新中心 | 山菅兰的活性提取物及其制备方法和应用 |
US11759435B2 (en) | 2016-04-28 | 2023-09-19 | Symrise Ag | Dihydrochalcone derivatives influencing inflammatory states |
CN108530273A (zh) * | 2018-04-26 | 2018-09-14 | 武汉桀升生物科技有限公司 | 一种2,4-二甲氧基-甲苯基-4-丙基间苯二酚的合成方法 |
CN110305014B (zh) * | 2019-03-15 | 2022-02-15 | 沈阳药科大学 | 环新木脂烷型木脂素对映异构体及其制备和应用 |
CN116196299B (zh) * | 2022-07-28 | 2023-10-03 | 昆明医科大学 | 1,3-二芳基丙烷类衍生物在制备酪氨酸酶抑制剂中的应用 |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA238730A (en) | 1924-03-18 | R. Curme Henry | Process of oxidising dibenzyl | |
US1596613A (en) * | 1925-12-15 | 1926-08-17 | Lehn & Fink Inc | 2, 4-dihydroxydiphenylethane and process of making it |
US3133967A (en) * | 1960-02-04 | 1964-05-19 | Boehringer Sohn Ingelheim | 1-(3, 4-dialkoxy-phenol)-1-dialkylamino-3-and-4-piienyl butanes |
JPS496311B1 (de) | 1970-01-09 | 1974-02-13 | ||
DE2644591A1 (de) | 1976-10-02 | 1978-04-06 | Bayer Ag | Verfahren zur herstellung von arylsulfoniumsalzen |
PT69349A (en) | 1978-03-15 | 1979-04-01 | Wellcome Found | Chemotherapeutic agent |
US5008294A (en) * | 1985-02-11 | 1991-04-16 | Chemex Pharmaceuticals, Inc. | Methods of treating tumors with compositions of catecholic butanes |
EP0028305B1 (de) | 1979-09-13 | 1984-02-01 | The Wellcome Foundation Limited | Diarylverbindungen und diese enthaltende pharmazeutische Zusammensetzungen |
JPS5758610A (en) | 1980-09-26 | 1982-04-08 | Lion Corp | Composition for oral cavity |
US4678664A (en) * | 1982-09-30 | 1987-07-07 | Basf Corporation | Mineral oil gels |
EP0122523A3 (de) | 1983-04-18 | 1987-05-27 | Andrews Paper and Chemical Co., Inc. | Diazotypiematerial und Zusammensetzung |
US4880637A (en) * | 1985-02-11 | 1989-11-14 | Chemex Pharmaceuticals, Inc. | Compositions of catecholic butanes with zinc |
KR890700023A (ko) * | 1986-11-19 | 1989-03-02 | 케맥스 파마슈우티칼스 인코포레이티드 | 리폭시게나제 저해제 |
FR2609711B1 (fr) | 1987-01-21 | 1989-06-16 | Rhone Poulenc Chimie | Procede de preparation d'hydroxybiphenyles |
US4954659A (en) * | 1987-10-21 | 1990-09-04 | Chemex Pharmaceuticals, Inc. | 1,4-bis (dihydroxyphenyl) butane and analogs |
CA1327869C (en) * | 1989-02-17 | 1994-03-15 | Yvan Guindon | Ribonucleotide reductase inhibitors |
JPH03242650A (ja) | 1990-02-20 | 1991-10-29 | Fuji Photo Film Co Ltd | ポジ型フオトレジスト組成物 |
JPH05213729A (ja) * | 1992-01-31 | 1993-08-24 | Kao Corp | メラニン抑制剤 |
US5430062A (en) * | 1992-05-21 | 1995-07-04 | Research Corporation Technologies, Inc. | Stilbene derivatives as anticancer agents |
EP0641301A1 (de) * | 1992-05-21 | 1995-03-08 | Research Corporation Technologies, Inc. | Stilbenderivate als antikrebsmittel |
IT1256354B (it) * | 1992-08-31 | 1995-12-01 | Francesca Pelizzoni | Derivati della combretastatina ad attivita' anti-tumorale e procedimento per la loro preparazione |
GB9322007D0 (en) * | 1993-10-26 | 1993-12-15 | Unilever Plc | Cosmetic composition |
US5585492A (en) * | 1994-10-11 | 1996-12-17 | G. D. Searle & Co. | LTA4 Hydrolase inhibitors |
US7056935B2 (en) * | 1995-06-07 | 2006-06-06 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
JPH08337510A (ja) * | 1995-06-15 | 1996-12-24 | Advanced Sukin Res Kenkyusho:Kk | メラニン生成抑制剤 |
JP3072267B2 (ja) * | 1995-11-24 | 2000-07-31 | 鐘紡株式会社 | ハイドロカルコン誘導体、該誘導体を含む化粧料及びこれらの製造方法 |
EP0811595B1 (de) * | 1995-11-24 | 2001-02-07 | Mitsui Chemicals, Inc. | Hydrochalconderivate, sie enthaltende kosmetische zusammensetzungen, und verfahren zur herstellung von beiden |
RU2156771C2 (ru) | 1996-05-30 | 2000-09-27 | Институт нефтехимии и катализа с опытным заводом АН РБ | Способ совместного получения 1-(диалкиламино)-2-фенилалюмациклопропана и 1-(диалкиламино)-2,4-дифенилалюмациклопентана |
DE19651681A1 (de) * | 1996-12-12 | 1998-06-18 | Basf Ag | Stabile, wäßrige Dispersionen und stabile, wasserdispergierbare Trockenpulver von Xanthopyllen, deren Herstellung und Verwendung |
ES2194303T3 (es) * | 1997-02-07 | 2003-11-16 | Aventis Pharma Inc | Derivados de (4-piperidinil)-1h-2-benzopirano utiles como agentes antipsicoticos. |
KR100270410B1 (ko) * | 1997-03-06 | 2000-11-01 | 성재갑 | 타이로시네이즈 활성 저해능을 갖는 신규 1,3-디페닐프로판 유도체 및 그의 제조방법 |
BR9803596A (pt) | 1997-09-23 | 2000-04-25 | Pfizer Prod Inc | Derivados do resorcinol. |
AU735737B2 (en) | 1997-10-14 | 2001-07-12 | Asahi Kasei Kabushiki Kaisha | Biphenyl-5-alkanoic acid derivatives and use thereof |
US6355683B1 (en) * | 1998-09-11 | 2002-03-12 | Ilexus Pty Limited | Fc receptor modulators and uses thereof |
JPH11255638A (ja) | 1998-03-13 | 1999-09-21 | Kansai Kouso Kk | チロシナーゼ活性阻害剤及び化粧料 |
US6296857B1 (en) * | 1998-09-23 | 2001-10-02 | Beiersdorf Aktiengesellschaft | Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation |
JP2000095721A (ja) | 1998-09-28 | 2000-04-04 | Mitsui Chemicals Inc | 新規ハイドロカルコン誘導体、該誘導体を含む化粧料およびこれらの製造方法 |
WO2000073269A2 (en) * | 1999-06-02 | 2000-12-07 | Regents Of The University Of Minnesota | Nicotine receptor ligands |
FR2796278B1 (fr) | 1999-07-16 | 2002-05-03 | Oreal | Utilisation d'au moins un hydroxystilbene comme agent anti-glycation |
US6214874B1 (en) * | 1999-10-15 | 2001-04-10 | John Hopkins University | Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N |
US6630510B1 (en) * | 1999-10-28 | 2003-10-07 | Merck & Co., Inc. | Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections |
US6221604B1 (en) | 2000-02-07 | 2001-04-24 | Pe Corporation | Electron-deficient nitrogen heterocycle-substituted fluorescein dyes |
WO2001064206A2 (en) | 2000-02-29 | 2001-09-07 | Integriderm, Inc. | Inhibitors of melanocyte tyrosinase as topical skin lighteners |
JP2001335472A (ja) | 2000-05-24 | 2001-12-04 | Kansai Koso Kk | チロシナーゼ活性阻害剤及び化粧料 |
AU2001271544A1 (en) * | 2000-06-30 | 2002-01-14 | The Procter And Gamble Company | Oral compositions comprising host-response modulating agent |
JP3504594B2 (ja) * | 2000-07-28 | 2004-03-08 | 株式会社ノエビア | 皮膚外用剤 |
WO2002024613A2 (en) | 2000-09-21 | 2002-03-28 | Pfizer Products, Inc. | Resorcinol derivatives |
ATE294806T1 (de) | 2000-09-21 | 2005-05-15 | Solvias Ag | Phosphinite-oxazoline und metallkomplexe |
DE10051034A1 (de) * | 2000-10-14 | 2002-04-18 | Henkel Kgaa | Oxidationsmittel enthaltend 2-Chlor-4-aminophenol |
WO2002035580A2 (en) | 2000-10-24 | 2002-05-02 | Molecular Electronics Corporation | Three-terminal field-controlled molecular devices |
HU227197B1 (en) | 2000-10-24 | 2010-10-28 | Richter Gedeon Nyrt | Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them |
JP2002193990A (ja) * | 2000-12-25 | 2002-07-10 | Mitsui Chemicals Inc | ハイドロカルコン配糖体および該配糖体を有効成分として配合した化粧料 |
AU2002231759B2 (en) | 2001-05-25 | 2006-08-03 | P&G Clairol, Inc. | 1,3-dihydroxybenzene derivatives and colorants containing said compounds |
AU2002319677B8 (en) * | 2001-07-23 | 2009-04-30 | Atwater Management Llc | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
GB0126889D0 (en) * | 2001-11-08 | 2002-01-02 | Paterson Inst For Cancer Res | Compounds and their uses |
DE10161253A1 (de) * | 2001-12-13 | 2003-06-26 | Dragoco Gerberding Co Ag | Verwendung von Dihydropinosylvin und dessen Derivaten als Inhibitoren |
US6562791B1 (en) * | 2002-03-29 | 2003-05-13 | Council Of Scientific And Industrial Research | Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof |
US7705188B2 (en) * | 2002-04-10 | 2010-04-27 | Arizona Board of Regents, a body corporate of the State of Arizona, Acting for and on Behalf of the Arizona State University | Structural modification of resveratrol: sodium resverastatin phosphate |
US6600004B1 (en) | 2002-04-10 | 2003-07-29 | General Electric Company | Method of preparing polyestercarbonates |
CN1462739A (zh) | 2002-05-30 | 2003-12-24 | 浙江工业大学 | 2,2'-二氨基联苄二磷酸盐低压液相催化加氢制备方法 |
CN1176964C (zh) | 2002-07-12 | 2004-11-24 | 丛树枫 | 弹性高强度聚氨酯预聚物的制备方法及其应用 |
SI1611112T1 (sl) | 2003-02-11 | 2012-12-31 | Vernalis (R&D) Limited | Izoksazolne spojine kot inhibitorji vroäśinskih ĺ ok proteinov |
CN1238361C (zh) | 2003-02-21 | 2006-01-25 | 南开大学 | 螺环双膦配体 |
DE10324566A1 (de) | 2003-05-30 | 2004-12-16 | Symrise Gmbh & Co. Kg | Verwendung von Diphenylmethan-Derivaten als Tyrosinase-Inhibitoren |
JP4569211B2 (ja) | 2003-07-31 | 2010-10-27 | 住友ベークライト株式会社 | フェノール化合物、ポジ型感光性樹脂組成物、半導体装置及び表示素子、並びに半導体装置及び表示素子の製造方法 |
JP2005097144A (ja) | 2003-09-24 | 2005-04-14 | Mitsubishi Chemicals Corp | 2核フェノール類の製造方法 |
ZA200609927B (en) * | 2004-05-28 | 2008-07-30 | Unigen Pharmaceuticals Inc | Diarylalkanes as potent inhibitors of binuclear enzymes |
US7334392B2 (en) | 2004-10-29 | 2008-02-26 | General Electric Company | Counter-rotating gas turbine engine and method of assembling same |
US20070224301A1 (en) | 2006-03-21 | 2007-09-27 | Ribnicky David M | Compounds from an extract of Artemisia and methods for treating disorders |
US7781410B2 (en) | 2006-08-04 | 2010-08-24 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing chalcones and use thereof |
KR102107460B1 (ko) | 2008-07-21 | 2020-05-08 | 유니젠, 인크. | 일련의 피부-화이트닝(라이트닝) 화합물 |
AU2012231008B2 (en) | 2011-03-24 | 2017-05-11 | Unigen, Inc. | Compounds and methods for preparation of diarylpropanes |
CA3034203C (en) | 2016-08-26 | 2022-06-21 | 1Qb Information Technologies Inc. | Method and system for performing real-time analytics on a plurality of data streams |
-
2005
- 2005-05-27 ZA ZA200809927A patent/ZA200609927B/en unknown
- 2005-05-27 CA CA2567801A patent/CA2567801C/en active Active
- 2005-05-27 US US11/139,200 patent/US20050267047A1/en not_active Abandoned
- 2005-05-27 RU RU2011133952/04A patent/RU2466981C1/ru not_active IP Right Cessation
- 2005-05-27 MX MXPA06013705A patent/MXPA06013705A/es active IP Right Grant
- 2005-05-27 AT AT05762186T patent/ATE538778T1/de active
- 2005-05-27 RU RU2006140961/04A patent/RU2006140961A/ru not_active Application Discontinuation
- 2005-05-27 CN CN2013102415226A patent/CN103356514A/zh active Pending
- 2005-05-27 KR KR1020067027751A patent/KR101236527B1/ko active IP Right Grant
- 2005-05-27 ES ES05762186T patent/ES2384506T3/es active Active
- 2005-05-27 CN CN2005800256816A patent/CN1993114B/zh active Active
- 2005-05-27 JP JP2007515432A patent/JP5128277B2/ja active Active
- 2005-05-27 CN CN2011100802598A patent/CN102210663B/zh active Active
- 2005-05-27 KR KR1020127026174A patent/KR20120117948A/ko not_active Application Discontinuation
- 2005-05-27 WO PCT/US2005/018884 patent/WO2005117849A1/en active Application Filing
- 2005-05-27 AU AU2005249493A patent/AU2005249493B2/en active Active
- 2005-05-27 EP EP05762186A patent/EP1748767B1/de active Active
- 2005-05-27 PL PL05762186T patent/PL1748767T3/pl unknown
- 2005-05-27 CN CN201811178200.0A patent/CN109134205B/zh active Active
-
2007
- 2007-03-13 HK HK07102730.4A patent/HK1095536A1/xx unknown
-
2008
- 2008-02-06 US US12/027,090 patent/US7767661B2/en active Active
-
2010
- 2010-06-11 US US12/814,190 patent/US8592488B2/en active Active
-
2012
- 2012-12-06 US US13/707,270 patent/US8729136B2/en active Active
-
2014
- 2014-03-13 US US14/209,814 patent/US9126913B2/en active Active
-
2015
- 2015-08-04 US US14/818,197 patent/US10548825B2/en active Active
-
2020
- 2020-02-03 US US16/780,018 patent/US10857082B2/en active Active
- 2020-12-07 US US17/113,193 patent/US11857657B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023200786A1 (en) | 2022-04-12 | 2023-10-19 | Unigen, Inc. | Diarylalkane compounds and compositions for use with skin aging and methods of production thereof |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1095536A1 (en) | 1-(3-methyl-2,4-dimethoxyphenyl)-3-(2',4'-dihydroxyphenyl)-propane as a potent tyrosinase inhibitor | |
WO2001070675A3 (en) | Inhibitors of histone deacetylase | |
WO2000061167A3 (en) | TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-λB ACTIVITY INHIBITORS | |
BR0317183A (pt) | Método de usar compostos de aminocianopiridina como inibidores de proteìna quinase-2 ativada por proteìna quinase ativada por mitógeno | |
MXPA04002397A (es) | Inhibidores de histona deacetilasa. | |
KR950702180A (ko) | 류코트리엔 생합성 억제제로서의 치환된 아릴알키닐-및 헤테로아릴알키닐-N-하이드록시우레아(substituted arylalkynyl-and heteroarylalkyny-N-hydroxyurea inhibi tors of leukotriene biosynthesis)본 내용은 요부공개 건이므로 전문 내용을 수록하지 않았음 | |
ATE244717T1 (de) | Inhibitoren des impdh-enzyms | |
NO20061194L (no) | Mitotiske kinesininbibitorer | |
BR0009167A (pt) | Inibidores de enzima impdh | |
ATE443043T1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
DE602004026407D1 (en) | Histondeacetylase-hemmer | |
MX2010014233A (es) | Compuestos quimicos 251. | |
BR0208373A (pt) | Inibidores da tirosina cinase | |
BG104780A (en) | Inhibitors of phospholipase enzymes | |
BR0306988A (pt) | Piridazinonas substituìdas como inibidores de p38 | |
EP1748046A3 (de) | Histon-Deacetylase Inhibitoren | |
MXPA05013224A (es) | Piridinilcarbamatos como inhibidores de lipasa sensible a hormonas. | |
MY148480A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MX2009011754A (es) | Inhibidores de enzima de diacilglicerol o-aciltransferasa tipo 1. | |
WO2002020475A3 (en) | Inhibitors of serine protease activity of matriptase or mtsp1 | |
WO2008014426A3 (en) | Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells | |
TW200637542A (en) | Lipase inhibitor, preventing and treating agent of skin disease | |
NO20062682L (no) | Farmasoytiske blandinger inneholdende forbindelser for inhibering av neoplastiske lesjoner | |
HRP20090407T1 (en) | Hair growth inhibition | |
ATE547105T1 (de) | Glucosamin und derivate davon als transglutaminase-inhibitoren zur verwendung in der behandlung von einer funktionsstörung des nervensystems |